title: Suprachoroidal implant surgery in intractable glaucoma.
abstract: OBJECTIVE
  To report the early results of suprachoroidal silicone implant surgery in intractable glaucoma.
  
  
  METHODS
  A modified silicone implant with no valve was implanted into the suprachoroidal space of 15 eyes with intractable glaucoma.
  
  
  RESULTS
  The mean age of the patients was 53.0 ± 24.5 (range 7-85) years, the mean follow-up time was 17.1 ± 4.8 (range 10-28) months, and the mean preoperative intraocular pressure (IOP) of patients receiving two or more medications was 33.1 ± 9.8 mmHg. At the last follow-up visit, mean IOP was 16.5 ± 7.9 (range 10-35) mmHg (Wilcoxon signed rank test, p = 0.001). The functional success, i.e., IOP ≤21 mmHg both with and without antiglaucomatous drugs, was 93.3%. The total success rate, i.e., IOP ≤21 mmHg without medication, was 13.3%. The average number of antiglaucomatous drugs used was 3.8 (range 2-5) preoperatively, and 2.2 postoperatively (range 0-4) (Wilcoxon signed rank test, p = 0.011). There was a ≥30% decrease in the IOP of 66.6% of the eyes. Shallow choroidal detachment as proof of drainage was evident in all cases.
  
  
  CONCLUSIONS
  Drainage of the aqueous humor from the anterior chamber to the suprachoroidal space via implantation of a modified silicone implant is effective in lowering the IOP in intractable glaucoma.
authors: Department of Ophthalmology, Faculty of Medicine, Ege University, 35100, Bornova, Izmir, Izmir, Turkey. melispalamar@hotmail.com.
authors: Melis
authors: M
authors: Palamar
authors: Department of Ophthalmology, Faculty of Medicine, Ege University, 35100, Bornova, Izmir, Izmir, Turkey.
authors: Halil
authors: H
authors: Ates
authors: Department of Ophthalmology, Faculty of Medicine, Ege University, 35100, Bornova, Izmir, Izmir, Turkey.
authors: Zafer
authors: Z
authors: Oztas
authors: Department of Ophthalmology, Faculty of Medicine, Ege University, 35100, Bornova, Izmir, Izmir, Turkey.
authors: Emil
authors: E
authors: Yusifov
references: Am J Ophthalmol. 1999 Apr;127(4):407-12
references: 10218693
references: Exp Eye Res. 1966 Jan;5(1):45-54
references: 4160221
references: Ophthalmology. 1992 Mar;99(3):438-44
references: 1565457
references: Arch Ophthalmol. 1991 Nov;109(11):1564-8
references: 1755739
references: J Glaucoma. 2003 Aug;12(4):354-9
references: 12897581
references: J Glaucoma. 2005 Apr;14(2):91-7
references: 15741807
references: Am J Ophthalmol. 1996 Aug;122(2):205-12
references: 8694088
references: Arch Ophthalmol. 2009 Mar;127(3):264-9
references: 19273788
references: Am J Ophthalmol. 1989 Dec 15;108(6):625-35
references: 2688428
references: Exp Eye Res. 1971 Nov;12(3):275-81
references: 5130270
references: J Glaucoma. 2006 Jun;15(3):200-5
references: 16778641
references: Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1653-64
references: 18682974
references: Arch Ophthalmol. 1973 Jan;89(1):10-2
references: 4684891